Summary & Overview
HCPCS G9050: Oncology Evaluation and Staging at Diagnosis or Recurrence
HCPCS Level II code G9050 denotes an oncology visit with a primary focus on work-up, evaluation, or staging performed at the time of a cancer diagnosis or recurrence. It is specific to services delivered under a Medicare-approved demonstration project and is intended to capture the clinical assessment and diagnostic staging activities that guide initial cancer management. Nationally, standardized reporting of these visits supports measurement of care coordination, timely diagnostic assessment, and outcomes tracking during the critical diagnostic period.
Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical intent and service setting, a summary of common modifiers and billing considerations (where provided), and context on where this code fits within oncology service lines. The publication highlights benchmarks and policy-relevant notes when available and identifies areas where input data was not provided.
This summary is intended for national audiences including payers, health system billing teams, and oncology program managers seeking clarity on the code’s purpose, expected sites of service, and how it maps to oncology evaluation and staging workflows. Data not available in the input.
Billing Code Overview
HCPCS Level II code G9050 describes oncology services with a primary focus on the visit that involves work-up, evaluation, or staging performed at the time of a cancer diagnosis or recurrence. This code is designated for use within a Medicare-approved demonstration project and captures the clinical activities tied to initial diagnostic assessment or restaging when cancer is suspected to be new or recurrent.
-
Service type: Oncology evaluation and staging, including diagnostic work-up and clinical assessment
-
Typical site of service: Hospital outpatient departments, oncology clinics, multidisciplinary cancer centers, or other ambulatory settings where diagnostic staging and initial oncology evaluations are performed
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 64-year-old patient presents to a oncology multidisciplinary clinic after a recent biopsy showing probable recurrent colorectal adenocarcinoma. The visit is billed under G9050 to capture the primary oncology-focused visit for work-up, evaluation, and staging at the time of cancer recurrence. The clinical workflow includes a focused oncology history and physical, review of prior pathology and imaging, ordering staging CT and PET scans, coordination of tumor board review, discussion of biopsy or molecular testing, and documentation of treatment intent (curative vs. palliative). The visit often involves review of performance status, comorbidities, prior therapies, and presenting symptoms; obtaining informed consent for diagnostic procedures; and planning next steps such as additional imaging, biopsy, referral to radiation or medical oncology, and scheduling of systemic therapy or clinical trial evaluation.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Default/No modifier | Use when no other modifier applies to the service billed with G9050. |
22 |